Search

1059 Result(s)
Sort by

Neovascular AMD (wet AMD)

Neovascular AMD (wet AMD)

Neovascular AMD (or wet AMD) is a severe form of advanced age-related macular degeneration that can lead to irreversible vision loss if untreated
Annual Results Press Conference 2023

Annual Results Press Conference 2023

Boehringer Ingelheim presents the 2022 results and an outlook for 2023 at the Annual Press Conference on March 29, 2023.
Innovation Prize Winners

Innovation Prize Winners

Find out more about the winners of our Innovation Prize in Boston, New York and San Diego in the USA; Tokyo Japan and Vienna, Austria
Transforming Science Day

Transforming Science Day

How our ‘patient first’ approach to innovation is aiming to accelerate breakthrough therapies that transform lives. Join our Transforming Science Day.
Work life balance

Work life balance

It's important that employees have a balance between professional and personal lives, so we offer various leave options and flexible working schedules.
Dominik Huber

Dominik Huber

Dominik Huber, Our Head of Upstream Manufacturing in Vienna, Dominik Huber, has built his entire, senior-level career with Boehringer Ingelheim.
Yanina Donatini

Yanina Donatini

Yanina Donatini, Head of ITM&S Content Production, jumped at the chance to fulfill her dreams within the Information Technology division at Boehringer Ingelheim.
Geographic Atrophy

Geographic Atrophy

Geographic atrophy (GA) is an advanced and severe form of dry age-related macular degeneration (AMD) that progresses slowly but can lead to permanent vision loss.
Collaboration in Oncology

Collaboration in Oncology

Oncology is a fast-moving, challenging and complex field and only with collaboration between different disciplines, we can be able to win the fight against cancer.
More Cherished Moments

More Cherished Moments

Innovation in healthcare is about more than just a new approach or technology. We innovate for better health of people and animals.